[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PT3775909T - Meios e métodos para o glicoperfil de uma proteína - Google Patents

Meios e métodos para o glicoperfil de uma proteína

Info

Publication number
PT3775909T
PT3775909T PT197185721T PT19718572T PT3775909T PT 3775909 T PT3775909 T PT 3775909T PT 197185721 T PT197185721 T PT 197185721T PT 19718572 T PT19718572 T PT 19718572T PT 3775909 T PT3775909 T PT 3775909T
Authority
PT
Portugal
Prior art keywords
glycoprofiling
protein
methods
Prior art date
Application number
PT197185721T
Other languages
English (en)
Original Assignee
Glycanostics S R O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glycanostics S R O filed Critical Glycanostics S R O
Publication of PT3775909T publication Critical patent/PT3775909T/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57434Specifically defined cancers of prostate
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415Assays involving biological materials from specific organisms or of a specific nature from plants
    • G01N2333/42Lectins, e.g. concanavalin, phytohaemagglutinin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701Details
    • G01N2333/4724Lectins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/02Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/70Mechanisms involved in disease identification
    • G01N2800/7095Inflammation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT197185721T 2018-03-26 2019-03-25 Meios e métodos para o glicoperfil de uma proteína PT3775909T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18163899 2018-03-26

Publications (1)

Publication Number Publication Date
PT3775909T true PT3775909T (pt) 2023-07-19

Family

ID=61800357

Family Applications (1)

Application Number Title Priority Date Filing Date
PT197185721T PT3775909T (pt) 2018-03-26 2019-03-25 Meios e métodos para o glicoperfil de uma proteína

Country Status (19)

Country Link
US (1) US20210048437A1 (pt)
EP (2) EP4253958A3 (pt)
JP (1) JP2021519443A (pt)
KR (1) KR102711673B1 (pt)
AU (1) AU2019246007A1 (pt)
CA (1) CA3091733A1 (pt)
DK (1) DK3775909T3 (pt)
ES (1) ES2950740T3 (pt)
FI (1) FI3775909T3 (pt)
HR (1) HRP20230744T1 (pt)
HU (1) HUE062414T2 (pt)
IL (1) IL277194A (pt)
LT (1) LT3775909T (pt)
PL (1) PL3775909T3 (pt)
PT (1) PT3775909T (pt)
RS (1) RS64431B1 (pt)
SI (1) SI3775909T1 (pt)
SM (1) SMT202300209T1 (pt)
WO (1) WO2019185515A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111208304B (zh) * 2020-01-20 2023-06-16 中国医学科学院北京协和医院 肿瘤来源IgG在甲状旁腺癌诊断和预后中的用途
JP7591205B2 (ja) 2020-09-01 2024-11-28 株式会社Jvcケンウッド 膵臓がんのデータ収集方法及び膵臓がん検出キット
CN113009130B (zh) * 2021-02-10 2022-08-23 中国医学科学院北京协和医院 一种用于诊断原发性干燥综合征的生物标志物及其用途
CN113009131B (zh) * 2021-02-10 2022-08-23 中国医学科学院北京协和医院 一种用于诊断原发性干燥综合征的生物标志物及其用途
WO2022186317A1 (ja) * 2021-03-03 2022-09-09 株式会社先端生命科学研究所 がん検出方法、がん検査方法、及びこれらに用いるキット
MX2024001598A (es) 2021-08-06 2024-02-15 Glycanostics S R O Estandar para el glicoperfilado de proteinas.
CN113702637B (zh) * 2021-08-09 2023-04-07 西北大学 乳腺癌新辅助化疗疗效预测的凝集素测试载体和试剂盒以及预测模型
CN113721029B (zh) * 2021-08-25 2023-06-06 西北大学 特定凝集素组合鉴别肝硬化、肝癌的测试工具及系统
EP4392780A1 (en) 2021-08-26 2024-07-03 Glycanostics s.r.o. Glycoprotein biomarkers for diagnosing cancer
CN118235044A (zh) 2021-09-14 2024-06-21 Glycanostics 公司 凝集素测定乳腺癌中乳腺珠蛋白-a糖型的应用
CN119301451A (zh) 2022-04-12 2025-01-10 Glycanostics 公司 用于蛋白质高通量糖谱分析的手段和方法
WO2024059750A2 (en) * 2022-09-16 2024-03-21 Venn Biosciences Corporation Diagnosis of ovarian cancer using targeted quantification of site-specific protein glycosylation
WO2024242050A1 (ja) * 2023-05-19 2024-11-28 学校法人創価大学 遺伝子疾患の検出方法

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US980A (en) 1838-10-13 Improvement in the mode of hardening or chilling the hubs of car and other wheels
US4816A (en) 1846-10-17 Bell machinery for hotels
US4676A (en) 1846-07-31 roller
US567A (en) 1838-01-09 Machine for r-uibbii
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US4676980A (en) 1985-09-23 1987-06-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Target specific cross-linked heteroantibodies
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
DE3883899T3 (de) 1987-03-18 1999-04-22 Sb2, Inc., Danville, Calif. Geänderte antikörper.
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
DE768377T1 (de) 1988-09-02 1998-01-02 Dyax Corp Herstellung und Auswahl von Rekombinantproteinen mit verschiedenen Bindestellen
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5859205A (en) 1989-12-21 1999-01-12 Celltech Limited Humanised antibodies
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
WO1992020791A1 (en) 1990-07-10 1992-11-26 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
GB9021679D0 (en) 1990-10-05 1990-11-21 Gorman Scott David Antibody preparation
ES2113940T3 (es) 1990-12-03 1998-05-16 Genentech Inc Metodo de enriquecimiento para variantes de proteinas con propiedades de union alteradas.
AU1545692A (en) 1991-03-01 1992-10-06 Protein Engineering Corporation Process for the development of binding mini-proteins
ATE414768T1 (de) 1991-04-10 2008-12-15 Scripps Research Inst Bibliotheken heterodimerer rezeptoren mittels phagemiden
EP0940468A1 (en) 1991-06-14 1999-09-08 Genentech, Inc. Humanized antibody variable domain
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
ATE390933T1 (de) 1995-04-27 2008-04-15 Amgen Fremont Inc Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8
AU2466895A (en) 1995-04-28 1996-11-18 Abgenix, Inc. Human antibodies derived from immunized xenomice
WO1997008320A1 (en) 1995-08-18 1997-03-06 Morphosys Gesellschaft Für Proteinoptimierung Mbh Protein/(poly)peptide libraries
KR100643058B1 (ko) 1996-12-03 2006-11-13 아브게닉스, 인크. 복수의 Vн 및 Vк 영역을 함유하는 인간 면역글로불린 유전자좌를 갖는 트랜스제닉 포유동물 및 이로부터 생성된 항체
EP1724282B1 (en) 1997-05-21 2013-05-15 Merck Patent GmbH Method for the production of non-immunogenic proteins
CA2342967A1 (en) 1998-12-08 2000-06-15 Biovation Limited Modifying protein immunogenicity
US7838634B2 (en) * 2005-04-15 2010-11-23 Van Andel Research Institute Methods for measuring glycan levels of proteins
JP4711190B2 (ja) * 2006-07-28 2011-06-29 国立大学法人 東京大学 グリコシル化異常症の検査方法
WO2009075883A2 (en) * 2007-12-12 2009-06-18 University Of Georgia Research Foundation, Inc. Glycoprotein cancer biomarker
US9169327B2 (en) 2008-03-12 2015-10-27 Rowan University Targeting of podoplanin with lectin for use in the prevention and treatment of cancer
JP2011529184A (ja) * 2008-07-25 2011-12-01 ザ・ジョンズ・ホプキンス・ユニバーシティ Psa糖鎖付加パターンを用いる前立腺癌の検出
JP2010091308A (ja) * 2008-10-04 2010-04-22 Sapporo Medical Univ レクチン吸収法による前立腺がんの診断方法及び判定キット

Also Published As

Publication number Publication date
IL277194A (en) 2020-10-29
LT3775909T (lt) 2023-08-10
JP2021519443A (ja) 2021-08-10
WO2019185515A1 (en) 2019-10-03
EP4253958A2 (en) 2023-10-04
HUE062414T2 (hu) 2023-10-28
HRP20230744T1 (hr) 2023-10-27
SMT202300209T1 (it) 2023-09-06
US20210048437A1 (en) 2021-02-18
KR20200138300A (ko) 2020-12-09
RS64431B1 (sr) 2023-09-29
EP3775909B1 (en) 2023-05-10
DK3775909T3 (da) 2023-07-24
EP3775909A1 (en) 2021-02-17
ES2950740T3 (es) 2023-10-13
FI3775909T3 (fi) 2023-08-01
PL3775909T3 (pl) 2023-09-18
EP4253958A3 (en) 2023-12-06
KR102711673B1 (ko) 2024-09-30
AU2019246007A1 (en) 2020-09-10
SI3775909T1 (sl) 2023-10-30
CA3091733A1 (en) 2019-10-03

Similar Documents

Publication Publication Date Title
IL277194A (en) Means and methods for glycoprofiling of protein
ZA202105676B (en) Anti-trem2 antibodies and related methods
IL272218A (en) ANTI-SIRP-ALPHA ANTIBODIES AND RELATED METHODS
IL276731A (en) Antibodies against CD73 and methods of using them
IL278821A (en) Anti-SIRPA antibodies and methods of using them
IL267861A (en) PD1-41BBL conjugate protein and methods of using it
ZA202003695B (en) Anti-neuropilin antigen-binding proteins and methods of use thereof
IL267862A (en) SIRPalpha-41BBL conjugate protein and methods of using it
IL270214A (en) Anti-sortilin antibodies and methods of using them
IL287318A (en) Materials and methods for the production of proteins
IL277212A (en) Anti-KLK5 antibodies and methods of use
SG11202012529VA (en) Means and methods for increased protein expression by use of transcription factors
IL283644A (en) Compositions and methods for immunotherapy
DK3737402T3 (en) Modificeret protein
ZA201907063B (en) Insecticidal proteins and methods for their use
SG11202013138RA (en) Anti-steap1 antigen-binding protein
IL276102A (en) System and method for characterizing protein dimerization
IL291284A (en) Systems and methods for expression of proteins
ZA202210284B (en) Anti-trem1 antibodies and related methods
GB201703416D0 (en) Method for protein expression
GB201818663D0 (en) Peptides and method
GB2575017B (en) Alignment Arrangement and Method of Alignment
GB201802757D0 (en) Analyitical method and means
GB201801920D0 (en) Polypeptides and methods
HK1218916A1 (zh) 種固定化蛋白的方法